Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Cash (2017 - 2021)

Cogent Biosciences has reported Change in Cash over the past 5 years, most recently at $16.8 million for Q4 2021.

  • Quarterly results put Change in Cash at $16.8 million for Q4 2021, down 85.11% from a year ago — trailing twelve months through Dec 2021 was -$22.5 million (down 110.99% YoY), and the annual figure for FY2025 was $214.3 million, up 376.82%.
  • Change in Cash for Q4 2021 was $16.8 million at Cogent Biosciences, up from -$15.2 million in the prior quarter.
  • Over the last five years, Change in Cash for COGT hit a ceiling of $112.8 million in Q4 2020 and a floor of -$15.2 million in Q3 2021.
  • Median Change in Cash over the past 5 years was -$2.5 million (2017), compared with a mean of $8.9 million.
  • Biggest five-year swings in Change in Cash: tumbled 497.02% in 2019 and later surged 1433.29% in 2020.
  • Cogent Biosciences' Change in Cash stood at -$2.4 million in 2017, then surged by 371.28% to $6.4 million in 2018, then plummeted by 232.67% to -$8.5 million in 2019, then surged by 1433.29% to $112.8 million in 2020, then plummeted by 85.11% to $16.8 million in 2021.
  • The last three reported values for Change in Cash were $16.8 million (Q4 2021), -$15.2 million (Q3 2021), and -$12.6 million (Q2 2021) per Business Quant data.